Cargando…
How I manage severe von Willebrand disease
Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Most patients with mild and moderate VWD can be treated effectively with desmopressin. The management of severe VWD patients, mostly affected by type 2 and type 3 disease, can be challenging. In this article we review the c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899759/ https://www.ncbi.nlm.nih.gov/pubmed/31498884 http://dx.doi.org/10.1111/bjh.16186 |
_version_ | 1783477201741545472 |
---|---|
author | Leebeek, Frank W. G. Atiq, Ferdows |
author_facet | Leebeek, Frank W. G. Atiq, Ferdows |
author_sort | Leebeek, Frank W. G. |
collection | PubMed |
description | Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Most patients with mild and moderate VWD can be treated effectively with desmopressin. The management of severe VWD patients, mostly affected by type 2 and type 3 disease, can be challenging. In this article we review the current diagnosis and treatment of severe VWD patients. We will also discuss the management of severe VWD patients in specific situations, such as pregnancy, delivery, patients developing alloantibodies against von Willebrand factor and VWD patients with recurrent gastrointestinal bleeding. Moreover, we review emerging treatments that may be applied in future management of patients with severe VWD. |
format | Online Article Text |
id | pubmed-6899759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68997592019-12-19 How I manage severe von Willebrand disease Leebeek, Frank W. G. Atiq, Ferdows Br J Haematol Reviews Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Most patients with mild and moderate VWD can be treated effectively with desmopressin. The management of severe VWD patients, mostly affected by type 2 and type 3 disease, can be challenging. In this article we review the current diagnosis and treatment of severe VWD patients. We will also discuss the management of severe VWD patients in specific situations, such as pregnancy, delivery, patients developing alloantibodies against von Willebrand factor and VWD patients with recurrent gastrointestinal bleeding. Moreover, we review emerging treatments that may be applied in future management of patients with severe VWD. John Wiley and Sons Inc. 2019-09-09 2019-11 /pmc/articles/PMC6899759/ /pubmed/31498884 http://dx.doi.org/10.1111/bjh.16186 Text en © 2019 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Reviews Leebeek, Frank W. G. Atiq, Ferdows How I manage severe von Willebrand disease |
title | How I manage severe von Willebrand disease |
title_full | How I manage severe von Willebrand disease |
title_fullStr | How I manage severe von Willebrand disease |
title_full_unstemmed | How I manage severe von Willebrand disease |
title_short | How I manage severe von Willebrand disease |
title_sort | how i manage severe von willebrand disease |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899759/ https://www.ncbi.nlm.nih.gov/pubmed/31498884 http://dx.doi.org/10.1111/bjh.16186 |
work_keys_str_mv | AT leebeekfrankwg howimanageseverevonwillebranddisease AT atiqferdows howimanageseverevonwillebranddisease |